Articles
-
1 week ago |
healio.com | Mark Leiser |Heather Biele |Gabrielle B. Rocque
Gabrielle B. Rocque, MD, MSPH, FASCO These investigators aimed to determine if a remote symptom monitoring program using electronic patient-reported outcomes improves fatigue among patients with metastatic breast cancer. This is an incredibly patient-centric question. Seventy percent of people in the study population had visceral disease and approximately half were on chemotherapy.
-
3 weeks ago |
healio.com | Jennifer Byrne |Mark Leiser
Key takeaways: More than half of individuals with lymphoma or multiple myeloma reported clinically significant anxiety or depression symptoms. Researchers recommended early screening for newly diagnosed patients. More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or depression, according to study results. Those symptoms correlated with reduced quality of life. Oreofe O.
-
3 weeks ago |
healio.com | Jennifer Byrne |Mark Leiser
The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine. The randomized phase 3 CheckMate 7FL trial included 510 patients with high-risk, early-stage ER-positive, HER2-negative breast cancer.
-
1 month ago |
healio.com | Jennifer Byrne |Mark Leiser |Donald Patrick
Key takeaways: Most people who used multicancer early detection tests reported high levels of satisfaction. Increases in anxiety after receipt of test results returned toward baseline at 12 months. The vast majority of individuals who used multicancer early detection tests reported being satisfied with the test, according to data from a prospective, multicenter cohort study.
-
1 month ago |
healio.com | Mark Leiser |Heather Biele |Premal Thaker
Premal H. Thaker, MD There have been many retrospective reports evaluating the benefit of radiation vs. cisplatin with concurrent radiation for patients with intermediate-risk criteria. In GOG-263, Ryu and colleagues prospectively evaluated this clinical question, and approximately 85% of patients could compete six cycles of cisplatin with concurrent chemoradiation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 12K
- Tweets
- 23K
- DMs Open
- No
Healio spoke with @IshwariaMD of @SarahCannonDocs about how validating the multitude of microtraumas that #oncologists experience can reduce #burnout. Researchers highlighted 6 areas that organizations should examine to improve oncologists’ well-being 👇 https://t.co/mF4EXHZXju https://t.co/PnvrP8YLgX
RT @HealioGastro: 📑@JAMAInternalMed data shows #statins may offer more than just lipid-lowering benefits for chronic #LiverDisease patients…
John V. Hillson, BA, DNP, AGNP-C, OCN, of @AtriumHealthWFB and @oncologynursing shares perspective on #ASTRO24 study that showed photon and proton beam radiation conferred similar outcomes for men with localized prostate cancer. #protontherapy https://t.co/jfUfYUWwtx https://t.co/3lbSYPwtJv